Home / People / Tomáš Matĕjovský
Portrait ofTomáš Matĕjovský

Tomáš Matĕjovský

Partner
Head of Commercial, Regulatory and Disputes, CMS Czech Republic

CMS Cameron McKenna Nabarro Olswang, advokáti, v.o.s.
Palladium, Na Poříčí 1079/3a
110 00 Prague 1
Czech Republic
Languages French, English, Czech
Commercial

Tomáš Matĕjovský is a partner and the Head of the Commercial, Regulatory and Disputes practice at CMS Prague.

He focuses on litigation and arbitration, compliance matters and white collar crime, and on commercial law, including employment, IP and competition. As part of his practice he represents clients in various types of litigations and arbitration proceedings at all levels, such as commercial, unfair competition and damage claim disputes before regional courts, Superior Courts, the Supreme Court, and the Constitutional Court and various arbitration bodies.

Tomáš also advises Czech and international companies on sector specific regulatory issues with particular focus on highly regulated industries such as the life sciences & healthcare, technology, media and communications sectors. His clients include major multinationals in these sectors.

In addition, he also supports clients on negotiating complex commercial agreements and advises on investments and investment incentives schemes in the CEE region.

more less

"Great knowledge of the legal system and excellent communication skills."

Chambers

Relevant experience

  • The Austrian and Slovak subsidiaries of Siemens in a major cross-border dispute over alleged pre-tender contractual liabilities linked to an important bidding process for railway security equipment.
  • Eastern Sugar in the Czech Republic in a EUR 41m claim against the Czech Republic.
  • Ministry of Agriculture concerning a wrongful allocation of its sugar quota and related significant ECHR claim against the Czech Republic.
  • Ministry of Finance of the Czech Republic in a significant arbitration valued at EUR 78.8m against a shareholder of a major Czech coal producer relating to a possible breach of a privatisation agreement by which the state's share was sold.
  • Global technology company and its insurers in a major multimillion euro damage claims regarding delivery and use of faulty electrical devices that caused a fire in one of the Prague’s main shopping gallery and office space in the centre of town, therefore representing a major health and safety risk.
  • A major telecommunications operator on the first stand-alone competition dispute with a competitor regarding margin squeeze in respect to providing of and access to broadband xDSL internet.
  • Diageo on the Czech regulation of food products and beverages, including labelling and packaging advice and distribution arrangements advice.
  • A leading biopharmaceutical company on all matters, including advising on employment law and lifesciences sector specific regulatory matters.
  • A global software company on several cyber-squatting and domain name matters and disputes as well as on trademark infringement issues, including oppositions against trademark applications.
  • A global IT company on several criminal investigations in relation to alleged bribery and corruption issues.
  • Worldwide medical devices producer on several compliance and anti-corruption investigations and relating matters. 
more less

Memberships & Roles

  • Czech Bar Association
  • ALAI Czech Republic
more less

Education

  • 1999 - International Law and State Administration Course, Ecole National d'Administration, Paris, France
  • 1998 - European Law, History and French Course, Universite de Perpignan, Perpignan, France
  • 1997 - Law Degree, Charles University, Prague
more less
Life Sciences & Healthcare

Tomáš Matĕjovský is a partner and the CEE Head of the Lifesciences & Healthcare sector group as well as Head of the Commercial, Regulatory and Disputes practice at CMS Prague.

He focuses on litigation and arbitration, compliance matters and white collar crime, and on commercial law, including employment, IP and competition. As part of his practice he represents clients in various types of litigations and arbitration proceedings at all levels, such as commercial, unfair competition and damage claim disputes before regional courts, Superior Courts, the Supreme Court, and the Constitutional Court and various arbitration bodies.

Tomáš advises various medical devices and pharmaceutical companies on various issues, including sector-specific regulatory matters, clinical trial problems and anti-corruption issues, as well as general commercial advice regarding company start-ups, distribution agreements and general day-to-day advice. He also advises on sector-specific regulatory issues in various due diligence processes.

In addition, he also supports clients on negotiating complex commercial agreements and advises on investments and investment incentives schemes in the CEE region.

more less

Relevant experience

  • A global pharmaceutical company | on regulatory data and patent protection against generics entry in the Czech Republic.
  • An original drug manufacturer | on regulatory data protection in the Czech Republic.
  • A French biopharmaceutical company | on its entry to the Czech market as well as on specific regulatory matters, including marketing authorisations relating to their pharmaceutical products, intellectual property rights with regards to trademarks, distribution in the Czech Republic, the establishment of distribution businesses in the Czech Republic and in Slovakia. This has included advising on structuring of the most efficient distribution models for both countries.
  • A global pharmaceutical corporation | on an internal investigation related to potential misconduct of their former Czech managing director, who was accused of unjustified preferential treatment, bossing some other employees and uneconomical conduct to the detriment of the company. We did a thorough audit of mailboxes of certain employees, conducted interviews with some of the employees and assisted the internal investigators of the corporation with some other tasks (review of accounting documents etc.).
  • A French biopharmaceutical company | on several proceedings against the Czech State Institute for Pharmaceuticals Control.
  • Various pharmaceutical companies | on various issues concerning public procurement issues in relation to public tenders, due diligence in public tender contracts, their participation in public tenders or their representation in administrative proceedings.
  • A pharmaceutical company | on distribution models (DTP), parallel trade issues as well as public procurement in the Czech Republic.
  • A global manufacturer of medical devices | providing ongoing legal advice to, pharmaceutical and consumer packaged goods on commercial law matters, including distribution systems and strategies, rebates as well as abuse of dominance.
  • A global medical products and technologies company | on pricing and reimbursement
  • A multinational biopharmaceutical company | in respect of its liability in the course of clinical trials of pharmaceuticals.
  • A multinational pharmaceutical company | in respect of a liability claim concerning defective medicinal product (vaccine).
more less

Memberships & Roles

  • Czech Bar Association
  • ALAI Czech Republic
more less

Education

  • 1999 - International Law and State Administration Course, Ecole National d'Administration, Paris, France
  • 1998 - European Law, History and French Course, Universite de Perpignan, Perpignan, France
  • 1997 - Law Degree, Charles University, Prague
more less
12/05/2022
10 key aspects of the revised EU competition law in the field of distribution...
The new Vertical Block Exemption Regulation (VBER) and the new accompanying Vertical Guidelines (VGL) were published on 10 May 2022. The new VBER will enter into force on 1 June 2022 and apply for the next twelve years. The new VBER/VGL introduce sev

Feed

13/02/2024
Are you a construction company and do you use subcontractors to complete...
From January, you are responsible for the wages of their employees.From 1 January 2024, contractors are legally liable for the wage claims of their subcontractors' employees (including "con­tract­ors")...
02/02/2024
Navigating Competition Compliance: The Czech Competition Authority outlines...
The Czech Office for Competition Protection (ÚOHS) has issued a new notice on competition compliance programmes effective from 1 January 2024. The notice sets out the conditions under which a compliance...
18/12/2023
Digital health apps and telemedicine in Slovakia
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? Software within digital health apps (the “DHA Software”)...
Comparable
04/12/2023
International arbitration law and rules in the Czech Republic
1 HISTORICAL BACKGROUND AND OVERVIEW 1.1.1 The pre-communist Czechoslovak legal roots were strongly influenced by the Austro-Hungarian legal system and, prior to 1939, commercial arbitration was well...
20/11/2023
Data protection and cybersecurity laws in Czech Republic
Data protection 1. Local data protection laws and scope Act No. 110/2019 Coll., on processing of personal data (hereinafter the “Data Processing Act”)Act No. 480/2004 Coll., on certain Information...
Comparable
09/11/2023
Groundbreaking ECJ ruling on annual leave entitlement of unlawfully dismissed...
On 12 October, the European Court of Justice (ECJ) adopted a landmark decision in Case C-57/22 - Ředitelství silnic a dálnic. The issue, brought before the ECJ by the Supreme Court of the Czech Republic...
08/11/2023
Cannabis law and legislation in Slovakia
Medical use It is not permitted to grow, import or sell cannabis for medical use in Slovakia. However, it is now permitted to grow cannabis for the research purposes, subject to approval granted by the...
16/08/2023
Whistleblower protection and reporting channels in Czech Republic
1. Is there a law on whistleblowing in your country? Yes. The Czech Whistleblower Protection Act (the “Act”) has been adopted and will become effective on 1 August 2023. 2. Does local law require...
Comparable
14/08/2023
CMS Expert Guide to Digital Litigation in Czech Republic
1. Describe the state of digitalisation of the civil justice system in your jurisdiction in general. Digitalisation of the Czech civil justice system has frequently been the subject of various drafts...
Comparable
21/07/2023
CMS International Patent Litigation Guide
Patented technology often ranks among a company's most valued as­sets. Pro­tect­ing your business from patent in­fringe­ment – or defending yourself against patent infringement claims of third parties – can be a complex and intensive process. CMS International Patent Litigation Guide (4th edition) is your essential tool to get an overview of the options and pathways to enforce patents in the courts of 18 major jurisdictions. Drawing on the expertise of CMS patent law specialists, this essential and fully-updated guide provides clear and concise coverage of patent infringement proceedings and practice. For each jurisdiction, you can quickly assess and compare critical issues such as:Standing - Who is entitled to sue for patent infringement, the number of parties that can be included in proceedings and time limits in which infringement claims must be boughtTiming and Forum – Where proceedings are brought, typical duration of trials and the handling of FRAND/compulsory licenses in court pro­ceed­ing­sEvid­ence – Use of expert witnesses, disclosure requirements and rules on seizure of evid­ence/doc­u­ment­s­Ap­peals – Routes, grounds and timings for appeal – and the potential interim enforcement of first instance de­cisionsCosts – Estimated legal costs, appeal costs and recoverability of litigation costsIn addition, the CMS International Patent Litigation Guide covers topics like Alternative Dispute Resolution, Remedies and Injunctions – and your CMS Patent Law team in each market. For dedicated information on the enforcement of European Patents before the Unified Patent Court please also visit our CMS UPC Insight  webpage.
26/06/2023
International Disputes Digest - 2023 Summer Edition
We are pleased to present the summer edition of the International Disputes Digest, our bi-annual publication bringing essential news and analysis on the latest trends in dis­pute-res­ol­u­tion around the world. There are many crises and problems that continue to complicate global business. These include inflation, particularly in the energy sector, as the EU and other regions struggle to wean themselves from Russian natural gas and oil. There is also the US debt crisis, which has weakened international confidence in the economy and distracted Washington from pressing issues, such as its relationship with China and the on-going war in the Ukraine. We hope that the articles in this digest provide readers with the know-how and tools to help them resolve any disputes or setbacks they may face. In this edition, we feature a range of articles from around the world on topics such as ESG litigation, the financial impact of cyber-attacks on businesses, post-merger disputes, the use of arbitration in resolving M&A-related issues, and how disputes can be managed in digital trade transactions. We also explore the reasons behind a wave of class action lawsuits in Portugal, the influence of personal relationships among arbitrators on disclosure, recusal, or appeals, and the 'without prejudice' principle, amongst other matters. We hope that you enjoy reading these articles and please do not hesitate to contact us should you wish to discuss any issues in relation to them.  
15/06/2023
Five misconceptions about the new Czech Whistleblower Protection Act
The legislative process of the Czech Whistleblower Protection Act (the “Act”), which transposes EU Directive 2019/1937 on the protection of persons who report breaches of Union law (the “Dir­ect­ive”)...